高级检索
当前位置: 首页 > 详情页

Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: National cross sectional study(Open Access)

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Endocrinology and Metabolism and the Instituteof Endocrinology, First Hospital of China Medical University, 155Nanjing Bei Street, Shenyang, 110001, Liaoning, China [2]Division of Endocrinology, Department of Internal Medicine, FirstAffiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China [3]Department of Endocrinology, First Affiliated Hospital of GuangxiMedical University, Nanning, Guangxi, China [4]Department of Endocrinology, Hainan General Hospital, Haikou,Hainan, China [5]Department of Endocrinology, First Affiliated Hospital of Xi’anJiaotong University, Xi’an, Shannxi, China [6]Department of Endocrinology, Union Hospital, Tongji MedicalCollege, Huazhong University of Science and Technology, Wuhan,Hubei, China [7]Department of Endocrinology, Chinese PLA General Hospital,Beijing, China [8]Department of Endocrinology, Southwest Hospital, Third MilitaryMedical University, Chongqing, China [9]Department of Endocrinology, First Affiliated Hospital of DalianMedical University, Dalian, Liaoning, China [10]Department of Endocrinology, Cardiovascular and CerebrovascularDisease Hospital of Ningxia Medical University, Yinchuan, Ningxia,P.R. China, 750004 [11]Department of Endocrinology and Metabolism, The SecondAffiliated Hospital of Nanchang University, Nanchang, Jiangxi, China [12]Department of Endocrinology, First Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang, China [13]Department of Endocrinology, Hohhot First Hospital, Hohhot,Inner Mongolia, China [14]Department of Endocrinology and Metabolism, Second XiangyaHospital, Central South University, Changsha, Hunan, China [15]Research Centre of Endocrine and Metabolic Diseases, AffiliatedHospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China [16]Department of Endocrinology and Metabolism, Fujian Institute ofEndocrinology, Fujian Medical University Union Hospital, Fuzhou,Fujian, China [17]Department of Endocrinology, First Hospital of Lanzhou University,Lanzhou, Gansu, China [18]Department of Endocrinology and Metabolism, State KeyLaboratory of Biotherapy, West China Hospital, Sichuan University,Chengdu, Sichuan, China [19]Department of Endocrinology and Metabolism, First Hospital ofJilin University, Changchun, Jilin, China [20]Department of Endocrinology, Shanghai University of Medicineand Health Science Affiliated Zhoupu Hospital, Shanghai, China [21]Department of Endocrinology, First Hospital of An Hui MedicalUniversity, Hefei, Anhui, China [22]Department of Endocrinology, First People’s Hospital of YunnanProvince, Kunming, Yunnan, China [23]Department of Endocrinology and Metabolism, Sun Yat-senMemorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China [24]Department of Endocrinology, First Hospital of Shanxi MedicalUniversity, Taiyuan, Shanxi, China [25]Department of Endocrinology and Metabolism, People’s Hospitalof Tibet Autonomous Region, Lhasa, Tibet, China [26]Department of Endocrinology, Qinghai Provincial People’sHospital, Xining, Qinghai, China [27]Zhejiang Provincial Centre for Disease Control and Prevention,Hangzhou, Zhejiang, China [28]Department of Endocrinology and Metabolism, Affiliated Hospitalof Guiyang Medical University, Guiyang, Guizhou, China [29]Department of Endocrinology, Second Hospital of Hebei MedicalUniversity, Shijiazhuang, Hebei, China [30]Department of Endocrinology, the First Affiliated Hospital ofXinjiang Medical University, Urumqi, Xinjiang, China [31]Department of Endocrinology and Metabolism, Tianjin MedicalUniversity General Hospital, Tianjin, China [32]Department of Endocrinology and Metabolism and the Instituteof Endocrinology, Rui-Jin Hospital affiliated with Shanghai Jiao-TongUniversity School of Medicine, Shanghai, China [33]Department of Endocrinology, Shandong Provincial Hospitalaffiliated with Shandong University, Jinan, Shandong, China
出处:
ISSN:

摘要:
Objective To assess the prevalence of diabetes and its risk factors. Design Population based, cross sectional study. Setting 31 provinces in mainland China with nationally representative cross sectional data from 2015 to 2017. Participants 75 880 participants aged 18 and older - a nationally representative sample of the mainland Chinese population. Main outcome measures Prevalence of diabetes among adults living in China, and the prevalence by sex, regions, and ethnic groups, estimated by the 2018 American Diabetes Association (ADA) and the World Health Organization diagnostic criteria. Demographic characteristics, lifestyle, and history of disease were recorded by participants on a questionnaire. Anthropometric and clinical assessments were made of serum concentrations of fasting plasma glucose (one measurement), two hour plasma glucose, and glycated haemoglobin (HbA 1c). Results The weighted prevalence of total diabetes (n=9772), self-reported diabetes (n=4464), newly diagnosed diabetes (n=5308), and prediabetes (n=27 230) diagnosed by the ADA criteria were 12.8% (95% confidence interval 12.0% to 13.6%), 6.0% (5.4% to 6.7%), 6.8% (6.1% to 7.4%), and 35.2% (33.5% to 37.0%), respectively, among adults living in China. The weighted prevalence of total diabetes was higher among adults aged 50 and older and among men. The prevalence of total diabetes in 31 provinces ranged from 6.2% in Guizhou to 19.9% in Inner Mongolia. Han ethnicity had the highest prevalence of diabetes (12.8%) and Hui ethnicity had the lowest (6.3%) among five investigated ethnicities. The weighted prevalence of total diabetes (n=8385) using the WHO criteria was 11.2% (95% confidence interval 10.5% to 11.9%). Conclusion The prevalence of diabetes has increased slightly from 2007 to 2017 among adults living in China. The findings indicate that diabetes is an important public health problem in China. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

基金:
语种:
高被引:
热点:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2019]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Endocrinology and Metabolism and the Instituteof Endocrinology, First Hospital of China Medical University, 155Nanjing Bei Street, Shenyang, 110001, Liaoning, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:83045 今日访问量:0 总访问量:682 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号